[Lys0] – γ – 1 – MSH (41 – 58), amide

[Lys0] – γ – 1 – MSH (41 – 58), amide

[Lys0] – γ – 1 – MSH (41 – 58), amide

[Lys0] – γ – 1 – MSH (41 – 58), amide

[Lys0] – γ – 1 – MSH (41 – 58), amide

[Lys⁰]-γ₁-MSH (41-58), amide is a synthetic peptide analog derived from the γ₁-melanocyte stimulating hormone, featuring an N-terminal lysine addition to the core 41-58 sequence with C-terminal amidation. This research-grade reagent is designed as a modified melanocortin receptor ligand with potential enhanced properties compared to the native peptide. The product is provided as a lyophilized powder with high purity and is intended for preclinical research applications in melanocortin receptor pharmacology, metabolic regulation studies, and structure-activity relationship investigations. It serves as a valuable tool for exploring the effects of N-terminal modifications on receptor binding affinity, selectivity, and biological activity in both academic and pharmaceutical research settings.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 [Lys0] – γ – 1 – MSH (41 – 58), amide
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
 C80H112N24O16S
Molecular Weight
 1698g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, physiological saline, or dilute acetic acid solution. It is recommended to first dissolve in a small volume of 0.1% acetic acid or sterile water to prepare a 1-5 mg/mL stock solution, then dilute to the working concentration with assay buffer.

Endotoxin< 1.0 EU/mg
Biological Activity
This peptide is an analog of γ₁-Melanocyte-Stimulating Hormone, expected to act as a ligand for melanocortin receptors (e.g., MC3R, MC5R). Biological activity should be confirmed through relevant functional assays such as cAMP accumulation in cells expressing target melanocortin receptors.
Storage Conditions
Lyophilized powder: Store desiccated at -20°C or below, protected from light, for long-term stability. Reconstituted solution: Aliquot and store at ≤-20°C. Avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

The mechanism of action involves binding to melanocortin receptors, primarily MC3R and potentially other receptor subtypes, acting as a ligand that may modulate receptor signaling. The N-terminal lysine addition (Lys⁰) is a structural modification designed to potentially influence receptor interaction, possibly affecting binding affinity, selectivity, or metabolic stability compared to the native γ₁-MSH sequence. Upon receptor engagement, the peptide is expected to trigger intracellular signaling cascades, potentially leading to cAMP accumulation through Gαs protein coupling, similar to other melanocortin peptides, although the specific pharmacological profile and receptor selectivity of this modified analog may differ from the endogenous ligand and require experimental characterization.


2.PRODUCT INDICATIONS

This γ₁-MSH analog is indicated for research use only in preclinical studies investigating melanocortin receptor biology, structure-activity relationships of melanocortin peptides, and the effects of N-terminal modifications on peptide function. It serves as a tool compound in receptor binding assays, functional assays measuring second messenger production, and comparative studies with other melanocortin analogs to understand how specific amino acid modifications influence receptor interaction and biological activity. The product is also used in metabolic regulation research and studies exploring the development of modified peptide therapeutics targeting melanocortin pathways. It is not intended for diagnostic, therapeutic, or clinical applications in humans or animals.


3.CLINICAL EFFICACY OF PRODUCT

As a research reagent, [Lys⁰]-γ₁-MSH (41-58), amide does not have established clinical efficacy for therapeutic use in human patients. This specific peptide analog has not undergone clinical development or received regulatory approval for any medical indication. While γ₁-MSH and related melanocortin peptides have been studied in preclinical models to understand their physiological roles, this particular modified analog remains an investigational research tool used primarily for structure-activity relationship studies and basic research purposes. It has no proven clinical efficacy or safety profile for human use and is intended solely for laboratory research applications.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.


Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.